Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Rhea-AI Summary
Anixa Biosciences (NASDAQ: ANIX), a biotechnology company specializing in cancer treatment and prevention, has announced its 2025 Annual Meeting of Stockholders scheduled for Thursday, March 20, 2025, at 10:00 a.m. Pacific Time. The meeting will be conducted in a virtual format.
The event will feature two main segments: first, the formal business and voting portion, followed by an investor presentation and corporate update by Chairman and CEO Dr. Amit Kumar. A question-and-answer session will conclude the meeting. The company has made the meeting accessible to all interested parties through their virtual platform at www.virtualshareholdermeeting.com/ANIX2025.
Positive
- None.
Negative
- None.
News Market Reaction – ANIX
On the day this news was published, ANIX declined 7.39%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Following the formal business and voting portion of the Meeting, Anixa Chairman and CEO Dr. Amit Kumar, will deliver an investor presentation and corporate update, followed by a question-and-answer session. All interested parties may attend the Meeting.
All parties may access the Meeting online at www.virtualshareholdermeeting.com/ANIX2025.
About Anixa Biosciences, Inc.
Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor-T cell (CER-T) technology. The Company's vaccine portfolio includes vaccines being developed in collaboration with Cleveland Clinic to treat and prevent breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms of cancer. Anixa's unique business model of partnering with world-renowned research institutions on all stages of development allows the Company to continually examine emerging technologies in complementary fields for further development and commercialization. To learn more, visit www.anixa.com or follow Anixa on Twitter, LinkedIn, Facebook and YouTube.
Forward-Looking Statements
Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect Anixa's current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in "Item 1A - Risk Factors" and other sections of our most recent Annual Report on Form 10-K as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release.
Contact:
Mike Catelani
President, COO & CFO
mcatelani@anixa.com
408-708-9808
View original content to download multimedia:https://www.prnewswire.com/news-releases/anixa-biosciences-2025-annual-meeting-of-stockholders-to-include-investor-presentation-open-to-all-interested-parties-302396784.html
SOURCE Anixa Biosciences, Inc.
FAQ
When is Anixa Biosciences (ANIX) 2025 Annual Meeting of Stockholders?
How can investors attend Anixa Biosciences (ANIX) 2025 Annual Meeting?
What will be presented at Anixa Biosciences (ANIX) 2025 Annual Meeting?
Is Anixa Biosciences (ANIX) 2025 Annual Meeting open to non-shareholders?
